Cargando…
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
BACKGROUND: Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations will inevitably develop drug resistance after being treated with the third-generation EGFR-tyrosine kinase inhibitor (TKI), osimertinib. Recently, the drug resistance information transmitte...
Autores principales: | Li, Xinying, Chen, Cen, Wang, Zimu, Liu, Jiaxin, Sun, Wei, Shen, Kaikai, Lv, Yanling, Zhu, Suhua, Zhan, Ping, Lv, Tangfeng, Song, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364701/ https://www.ncbi.nlm.nih.gov/pubmed/34391435 http://dx.doi.org/10.1186/s12935-021-02075-8 |
Ejemplares similares
-
Exosomal miRNAs in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2020) -
Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Identify Leptomeningeal Metastasis in Non-Small Cell Lung Cancer
por: Xu, Qiuli, et al.
Publicado: (2021) -
The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015) -
Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells
por: Sikand, Kavleen, et al.
Publicado: (2009) -
Three miRNAs cooperate with host genes involved in human cardiovascular disease
por: Zhu, Yan, et al.
Publicado: (2019)